Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Cyclomethicone BP EP USP Pharma Grade describes a clear, colorless liquid, notable in pharmaceutical manufacturing for its excellent fluidity and volatility. This grade follows British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) standards, covering the strictest benchmarks for consistency and purity. Chemically, cyclomethicone comes from a family of cyclic siloxane compounds. The molecular formula typically appears as (C2H6OSi)n, reflecting its makeup of repeating dimethylsiloxane units. Depending on the value of “n,” the resulting structure can feature between four and six silicon-oxygen rings, affecting viscosity, evaporation rate, and volatility. The material’s distinctive ring formation gives cyclomethicone its signature silky feel and spreadability, qualities appreciated in various topical drug formulations and cosmetic bases.
Within manufacturing and preparation environments, cyclomethicone BP EP USP Pharma Grade comes as a water-thin, mobile liquid. Transparent and nearly odorless, the material does not stain. Processing and storage often require steel or glass containers to prevent contamination and preserve chemical integrity. Typical density ranges from 0.950 to 0.970 g/cm³ at 25°C, a lighter value than water, causing the liquid to float when mixed. The molecular weight for common grades, such as D4 and D5, lands in the 297 to 370 g/mol range, shaping how quickly the chemical evaporates after application. As for physical forms, cyclomethicone stays liquid at room temperature and resists changing into solid forms like flakes, powder, or pearls under standard industry storage and distribution. It remains stable under most atmospheric conditions, resisting solidification and crystal formation below −40°C.
Each molecule consists of a backbone made from alternating silicon and oxygen atoms, where each silicon holds two methyl groups. This structure can be written as [(CH3)2SiO]n. The ring size may differ—tetramethyltetrasiloxane (octamethylcyclotetrasiloxane, or D4) uses four units, while pentamethylpentasiloxane (decamethylcyclopentasiloxane, or D5) uses five, and so on. These cyclic structures are responsible for cyclomethicone’s low surface tension, rapid evaporation, and ability to carry active ingredients over skin or tablet surfaces without leaving residue or interfering with drug activity.
Regarding safety and quality, BP, EP, and USP certifications serve as guarantees on impurity limits, sterility, and traceable origin. The specifications demand purity levels above 98%, with permissible levels of volatile impurities and heavy metals set well below legal thresholds. Cyclomethicone’s flash point typically occurs above 76°C, while its boiling range extends from about 175°C to 210°C, indicating care is needed with storage near ignition sources despite its chemical stability. Material Safety Data Sheet (MSDS) data point to low direct toxicity but recommend minimizing inhalation and prolonged skin exposure, as irritation can develop in sensitive individuals or with repeated heavy contact.
Cyclomethicone products meant for export and cross-border shipping often use the international HS Code 39100000, which relates to polysiloxanes in primary forms. Accurate classification ensures regulatory compliance and smooth logistics through customs checkpoints. On invoices and shipment manifests, this designation aligns with commonly accepted nomenclature for silicon-based synthetic resins under the harmonized trade system.
For chemists and material handlers, cyclomethicone’s volatility means keeping containers tightly shut in well-ventilated, dry storage rooms. Cyclomethicone resists hydrolysis under most ambient conditions, but exposure to strong acids or bases can break the siloxane bond, degrading the product. In production, laboratories monitor batch integrity using gas chromatography and other methods to confirm ring size, viscosity, and contaminant levels. Well-known as a solvent and carrier, cyclomethicone finds place in topical solutions and certain raw material formulations for drug-coated tablets. Its rapid evaporation means it can deliver actives efficiently but disappear swiftly from the application site.
Environmentalists keep a close eye on cyclomethicone release, since waste streams can carry residues into water systems. Studies show D4 and D5 build up slowly but can appear in aquatic environments. International consensus points toward restricting environmental discharge and developing recycling protocols where practical. Factories and plants often adopt closed-loop or waste reclamation systems to allow recovery and reduce impact. Cyclomethicone’s low acute human toxicity marks it as generally safe for workers using standard personal protective equipment; gloves and goggles remain a base precaution. For people using finished products, published literature places it as low risk when formulated within guidelines set out by regulatory bodies. Careful monitoring of inhalation exposure in manufacturing remains necessary to prevent possible long-term effects that remain under study.
Industries working with cyclomethicone BP EP USP Pharma Grade can improve safety and sustainability by focusing on batch traceability, adopting real-time monitoring for airborne siloxanes, and recycling spent material wherever feasible. Substituting lower-vapor-pressure cyclics or linear siloxanes offers alternative paths, especially when regulatory limits narrow. Research into biodegradable replacements is underway, though no direct one-to-one substitute gives the same balance of volatility, viscosity, and spread at similar cost or safety. By staying ahead of evolving safety data and adopting best practices for handling and waste reduction, the pharmaceutical sector keeps benefit levels high and risks low, for both workers and end users.
Chengguan District, Lanzhou, Gansu, China
